Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Nemaura Medical Inc. | ex32x1.htm |
| EX-31.2 - EXHIBIT 31.2 - Nemaura Medical Inc. | ex31x2.htm |
| EX-31.1 - EXHIBIT 31.1 - Nemaura Medical Inc. | ex31x1.htm |
| EX-23.1 - EXHIBIT 23.1 - Nemaura Medical Inc. | ex23x1.htm |
| EX-21.1 - EXHIBIT 21.1 - Nemaura Medical Inc. | ex21x1.htm |
| EX-4.3 - EXHIBIT 4.3 - Nemaura Medical Inc. | ex4x3.htm |
| 10-K - FORM 10-K - Nemaura Medical Inc. | nmra_10k-033120.htm |
EXHIBIT 32.2
WRITTEN STATEMENT
PURSUANT TO
18 U.S.C. SECTION 1350
In connection with Annual Report of Nemaura Medical Inc. and its subsidiaries (the “ Company ”) on Form 10-K for the year ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Dr. D.F.H. Chowdhury, Interim Chief Financial Officer (Principal Financial Officer) of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13a-14(b) or 15d-14(b) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated June 29, 2020 | By: | /s/ Dr. D. F.H. Chowdhury |
| Name: | Dr. D. F.H. Chowdhury | |
| Title: | Interim Chief Financial Officer (Principal Financial Officer) |